Menin is required in cranial neural crest for palatogenesis and perinatal viability

Developmental Biology

Volumn 311, Issue 2, 2007, Pages 524-537

  Engleka, Kurt A ^a   Wu, Meilin ^a   Zhang, Maozhen ^a   Antonucci, Nicole B ^a   Epstein, Jonathan A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Menin; Neural crest; Osteogenesis; Palatogenesis; Pax3

Indexed keywords

ACTIN; CELL CYCLE INHIBITOR; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 1B; HISTONE METHYLTRANSFERASE; MENIN PROTEIN; NUCLEAR PROTEIN; PROTEIN P27; TRANSCRIPTION FACTOR PAX3; UNCLASSIFIED DRUG; WNT1 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DEFECT; BONE DEVELOPMENT; CELL CYCLE; CELL VIABILITY; CLEFT PALATE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE MUTATION; IN VIVO STUDY; MOUSE; MULTIPLE ENDOCRINE NEOPLASIA; NEURAL CREST; NEWBORN; NONHUMAN; PALATE; PERINATAL DEATH; PERINATAL DEVELOPMENT; PRIORITY JOURNAL; TISSUE SPECIFICITY; TUMOR SUPPRESSOR GENE;

EID: 35748972088     PISSN: 00121606     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ydbio.2007.08.057     Document Type: Article

References (55)

1. Agah R., Frenkel P.A., French B.A., Michael L.H., Overbeek P.A., and Schneider M.D. Gene recombination in postmitotic cells: targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. J. Clin. Invest. 100 (1997) 169-179
2. Agarawal S.K., Impey S., McWeeney S., Scacheri P.C., Collins F.S., Goodman R.H., Spiegel A.M., and Marx S.J. Distribution of menin-occupied regions in chromatin specifies a broad role of menin in transcriptional regulation. Neoplasia 9 (2007) 101-107
3. Agarwal S.K., Kennedy P.A., Scacheri P.C., Novotny E.A., Hickman A.B., Cerrato A., Rice T.S., Moore J.B., Rao S., Ji Y., Mateo C., Libutti S.K., Oliver B., Chandrasekharappa S.C., Burns A., Collins L., Spiegel F.S., and Marx A.M. Menin molecular interactions: insights into normal functions and tumorigenesis. Horm. Metab. Res. 37 (2005) 369-374
4. Bertolino P., Radovanovic I., Casse H., Aguzzi A., Wang Z.Q., and Zhang C.X. Genetic ablation of the tumor suppressor menin causes lethality at mid-gestation with defects in multiple organs. Mech. Dev. 120 (2003) 549-560
5. Bertolino P., Tong W.M., Galendo D., Wang Z.Q., and Zhang C.X. Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1. Mol. Endocrinol. 17 (2003) 1880-1892
6. Bertolino P., Tong W.M., Herrera P.L., Casse H., Zhang C.X., and Wang Z.Q. Pancreatic beta-cell-specific ablation of the multiple endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma development in mice. Cancer Res. 63 (2003) 4836-4841
7. Biondi C.A., Gartside M.G., Waring P., Loffler K.A., Stark M.S., Magnuson M.A., Kay G.F., and Hayward N.K. Conditional inactivation of the MEN1 gene leads to pancreatic and pituitary tumorigenesis but does not affect normal development of these tissues. Mol. Cell. Biol. 24 (2004) 3125-3131
8. Chai Y., and Maxson Jr. R.E. Recent advances in craniofacial morphogenesis. Dev. Dyn. 235 (2006) 2353-2375
9. Chai Y., Jiang X., Ito Y., Bringas Jr. P., Han J., Rowitch D.H., Soriano P., McMahon A.P., and Sucov H.M. Fate of the mammalian cranial neural crest during tooth and mandibular morphogenesis. Development 127 (2000) 1671-1679
10. Chandrasekharappa S.C., and Teh B.T. Functional studies of the MEN1 gene. J. Intern. Med. 253 (2003) 606-615
11. Chandrasekharappa S.C., Guru S.C., Manickam P., Olufemi S.E., Collins F.S., Emmert-Buck M.R., Debelenko L.V., Zhuang Z., Lubensky I.A., Liotta L.A., Crabtree J.S., Wang Y., Roe B.A., Weisemann J., Boguski M.S., Agarwal S.K., Kester M.B., Kim Y.S., Heppner C., Dong Q., Spiegel A.M., Burns A.L., and Marx S.J. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276 (1997) 404-407
12. Chen Y.X., Yan J., Keeshan K., Tubbs A.T., Wang H., Silva A., Brown E.J., Hess J.L., Pear W.S., and Hua X. The tumor suppressor menin regulates hematopoiesis and myeloid transformation by influencing Hox gene expression. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 1018-1023
13. Crabtree J.S., Scacheri P.C., Ward J.M., Garrett-Beal L., Emmert-Buck M.R., Edgemon K.A., Lorang D., Libutti S.K., Chandrasekharappa S.C., Marx S.J., Spiegel A.M., and Collins F.S. A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 1118-1123
14. Crabtree J.S., Scacheri P.C., Ward J.M., McNally S.R., Swain G.P., Montagna C., Hager J.H., Hanahan D., Edlund H., Magnuson M.A., Garrett-Beal L., Burns A.L., Ried T., Chandrasekharappa S.C., Marx S.J., Spiegel A.M., and Collins F.S. Of mice and MEN1: insulinomas in a conditional mouse knockout. Mol. Cell. Biol. 23 (2003) 6075-6085
15. Danielian P.S., Muccino D., Rowitch D.H., Michael S.K., and McMahon A.P. Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase. Curr. Biol. 8 (1998) 1323-1326
16. Dixon J., and Dixon M.J. Genetic background has a major effect on the penetrance and severity of craniofacial defects in mice heterozygous for the gene encoding the nucleolar protein Treacle. Dev. Dyn. (2004) 907-914
17. Dreijerink K.M.A., Mulder K.W., Winkler G.S., Hoppener J.W., Lips C.J., and Timmers H.T. Menin links estrogen receptor activation to histone H3K4 trimethylation. Cancer Res. 66 (2006) 4929-4935
18. Echelard Y., Vassileva G., and McMahon A.P. Cis-acting regulatory sequences governing Wnt-1 expression in the developing mouse CNS. Development 120 (1994) 2213-2224
19. Engleka K.A., Gitler A.D., Zhang M., Zhou D.D., High F.A., and Epstein J.A. Insertion of Cre into the Pax3 locus creates a new allele of Splotch and identifies unexpected Pax3 derivatives. Dev. Biol. 280 (2005) 396-406
20. Franklin D.S., Godfrey V.L., Lee H., Kovalev G.I., Schoonhoven R., Chen-Kiang S., Su L., and Xiong Y. CDK inhibitors p18 INK4c and p27 KIP1 mediate two separate pathways to collaboratively suppress pituitary tumorigenesis. Genes Dev. 12 (1998) 2899-2911
21. Franklin D.S., Godfrey V.L., Deng O.B., and Xiong C. Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity. Mol. Cell. Biol. 20 (2000) 6147-6158
22. Gritli-Linde A. Molecular control of secondary palate development. Dev. Biol. 301 (2007) 309-326
23. Guccione E., Martinato F., Finocchiaro G., Luzi L., Tizzoni L., Dall'Olio V., Zardo G., Nervi C., Bernard L., and Amati B. Myc-binding-site recognition in the human genome is determined by chromatin context. Nat. Cell Biol. 8 (2006) 764-770
24. Guenther M.G., Jenner R.G., Chevalier B., Nakamura T., Croce C.M., Canaani E., and Young R.A. Global and Hox-specific roles for the MLL1 methyltransferase. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 8603-8608
25. Hahm K., Sum E.Y., Fujiwara Y., Lindeman G.J., Visvader J.E., and Orkin S.H. Defective neural tube closure and anteroposterior patterning in mice lacking the LIM protein LMO4 or its interacting partner Deaf-1. Mol. Cell. Biol. 24 (2004) 2074-2082
26. Henderson D.J., Conway S.J., and Copp A.J. Rib truncations and fusions in the Sp2H mouse reveal a role for Pax3 in specification of the ventro-lateral and posterior parts of the somite. Dev. Biol. 209 (1999) 143-158
27. High F.A., Zhang M., Proweller A., Tu L., Parmacek M.S., Pear W.S., and Epstein J.A. An essential role for Notch in neural crest during cardiovascular development and smooth muscle differentiation. J. Clin. Invest. 117 (2007) 353-363
28. Hughes C.M., Rozenblatt-Rosen O., Milne T.A., Copeland T.D., Levine S.S., Lee J.C., Hayes D.N., Shanmugam K.S., Bhattacharjee A., Biondi C.A., Kay G.F., Hayward N.K., Hess J.L., and Meyerson M. Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus. Mol. Cell 13 (2004) 587-597
29. Karnik S.K., Hughes C.M., Gu X., Rozenblatt-Rosen O., McLean G.W., Xiong Y., Meyerson M., and Kim S.K. Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 14659-14664
30. Li J., Chen F., and Epstein J.A. Neural crest expression of Cre recombinase directed by the proximal Pax3 promoter in transgenic mice. Genesis 26 (2000) 162-164
31. Mao X., Fujiwara Y., and Orkin S.A. Improved reporter strain for monitoring Cre recombinase-mediated DNA excisions in mice. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 5037-5042
32. Martin J.F., Bradley A., and Olson E.N. The paired-like homeo box gene MHox is required for early events of skeletogenesis in multiple lineages. Genes Dev. 9 (1995) 1237-1249
33. Marx S.J. Molecular genetics of multiple endocrine neoplasia types 1 and 2. Nat. Rev., Cancer 5 (2005) 367-375
34. Milne T.A., Hughes C.M., Lloyd R., Yang Z., Rozenblatt-Rosen O., Dou Y., Schnepp R.W., Krankel C., Livolsi V.A., Gibbs D., Hua X., Roeder R.G., Meyerson M., and Hess J.L. Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 749-754
35. Naito J., Kaji H., Sowa H., Hendy G.N., Sugimoto T., and Chihara K. Menin suppresses osteoblast differentiation by antagonizing the AP-1 factor, JunD. J. Biol. Chem. 280 (2005) 4785-4791
36. Pellegata N.S., Quintanilla-Martinez L., Siggelkow H., Samson E., Bink K., Höfler H., Fend F., Graw J., and Atkinson M.J. Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 15558-15563
37. Qiu M., Bulfone A., Martinez S., Meneses J.J., Shimamura K., Pederson R.A., and Rubenstein J.L.R. Null mutation of Dlx-2 results in abnormal morphogenesis of proximal first and second branchial arch derivatives and abnormal differentiation in the forebrain. Genes Dev. 9 (1995) 2523-2538
38. Rivera-Pérez J.A., Mallo M., Gendron-Maguire M., Gridley T., and Behringer R.R. Goosecoid is not an essential component of the mouse gastrula organizer but is required for craniofacial and rib development. Development 121 (1995) 3005-3012
39. Saint-Jeannet J.-P. Neural crest induction and differentiation. Advances in Experimental Medicine and Biology vol. 589 (2006), Springer, New York
40. Santos-Rosa H., Schneider R., Bannister A.J., Sherriff J., Bernstein B.E., Emre N.C., Schreiber S.L., Mellor J., and Kouzarides T. Active genes are tri-methylated at K4 of histone H3. Nature 419 (2002) 407-411
41. Satokata I., and Maas R. Msx1-deficient mice exhibit cleft palate and abnormalities of craniofacial and tooth development. Nat. Genet. 6 (1994) 348-355
42. Scacheri P.C., Crabtree J.S., Kennedy A.L., Swain G.P., Ward J.M., Marx S.J., Spiegel A.M., and Collins F.S. Homozygous loss of menin is well tolerated in liver, a tissue not affected in MEN1. Mamm. Genome 15 (2004) 872-877
43. Scacheri P.C., Davis S., Odom D.T., Crawford G.E., Perkins S., Halawi M.J., Agarwal S.K., Marx S.J., Spiegel A.M., Meltzer P.S., and Collins F.S. Genome-wide analysis of menin binding provides insights into MEN1 tumorigenesis. PLoS Genet. 4 (2006) e51
44. Schneider R., Bannister A.J., Myers F.A., Thorne A.W., Crane-Robinson C., and Kouzarides T. Histone H3 Lysine 4 methylation patterns in higher eukaryotic genes. Nat. Cell Biol. 6 (2004) 73-77
45. Schnepp R.W., Hou Z., Wang H., Petersen C., Silva A., Masai H., and Hua X. Functional interaction between tumor suppressor menin and activator of S-phase kinase. Cancer Res. 64 (2004) 6791-6796
46. Schnepp R.W., Mao H., Sykes S.M., Zong W.X., Silva A., La P., and Hua X. Menin induces apoptosis in murine embryonic fibroblasts. J. Biol. Chem. 279 (2004) 10685-10691
47. Shamblott M.J., Bugg E.M., Lawler A.M., and Gearhart J.D. Craniofacial abnormalities resulting from targeted disruption of the murine Sim2 gene. Dev. Dyn. 224 (2002) 373-380
48. Sock E., Rettig S.D., Enderich J., Bösl M.R., Tamm E.R., and Wegner M. Gene targeting reveals a widespread role for the high-mobility-group transcription factor Sox11 in tissue remodeling. Mol. Cell. Biol. 24 (2004) 6635-6644
49. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 21 (1999) 70-71
50. Sowa H., Kaji H., Canaff L., Hendy G.N., Tsukamoto T., Yamaguchi T., Miyazono K., Sugimoto T., and Chihara K. Inactivation of menin, the product of the multiple endocrine neoplasia type 1 gene, inhibits the commitment of multipotential mesenchymal stem cells into the osteoblast lineage. J. Biol. Chem. 278 (2003) 21058-21069
51. Sowa H., Kaji H., Hendy G.N., Canaff L., Komori T., Sugimoto T., and Chihara K. Menin is required for bone morphogenetic protein 2- and transform ing growth factor β-regulated osteoblastic differentiation through interaction with Smads and Runx2. J. Biol. Chem. 279 (2004) 40267-40275
52. Stoller J.Z., and Epstein J.A. Cardiac neural crest. Semin Cell Dev. Biol. 16 (2005) 704-715
53. Yokoyama A., Wang Z., Wysocka J., Sanyal M., Aufiero D.J., Kitabayashi I., Herr W., and Cleary M.L. Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression. Mol. Cell. Biol. 24 (2004) 5639-5649
54. Yokoyama A., Somervaille T.C., Smith K.S., Rozenblatt-Rosen O., Meyerson M., and Cleary M.L. The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis. Cell 123 (2005) 207-218
55. Zhang P., Liégeois J.J., Wong C., Finegold M., Hou H., Thompson J.C., Silverman A., Harper J.W., DePinho R.A., and Elledge S.J. Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature 387 (1997) 151-158